Literature DB >> 12612916

American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12612916     DOI： 10.1053/gast.2003.50107

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  44 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 2.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

Review 3.  Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors:  Paul E Evans; Darrell S Pardi
Journal:  MedGenMed       Date:  2007-03-19

4.  Risk of diagnosed fractures in children with inflammatory bowel diseases.

Authors:  Michael D Kappelman; Joseph A Galanko; Carol Q Porter; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

Review 5.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 6.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

7.  Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Authors:  Zhuo Yang; Nick Clark; K T Park
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-21       Impact factor: 11.382

8.  Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.

Authors:  C L Gregson; E M Dennison; J E Compston; S Adami; J D Adachi; F A Anderson; S Boonen; R Chapurlat; A Díez-Pérez; S L Greenspan; F H Hooven; A Z LaCroix; J W Nieves; J C Netelenbos; J Pfeilschifter; M Rossini; C Roux; K G Saag; S Silverman; E S Siris; N B Watts; A Wyman; C Cooper
Journal:  Osteoporos Int       Date:  2013-07-25       Impact factor: 4.507

Review 9.  Exercise and inflammatory bowel disease.

Authors:  Neeraj Narula; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

10.  The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Authors:  A R Moschen; A Kaser; B Enrich; O Ludwiczek; M Gabriel; P Obrist; A M Wolf; H Tilg
Journal:  Gut       Date:  2005-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.